How to Get GLP-1 in Nebraska for Weight Loss
The short answer
In Nebraska, 37.6% of adults have obesity (2024 CDC data), which is higher than the national rate of 33.1%. Transformation Health does not currently offer its compounded GLP-1 program to Nebraska residents, so this page focuses on the Nebraska obesity and Medicaid data rather than enrollment. GLP-1 medications remain one option to discuss with a locally licensed provider.
Obesity and metabolic health in Nebraska
Adults with obesity (2024)
37.6%
Obesity rank of 51 (1 = highest)
#7
No leisure-time physical activity (2024)
21.6%
Adult obesity prevalence in Nebraska is 37.6%, compared with 33.1% nationally (2024). That places Nebraska the 7th highest of the 51 states and DC.
On physical activity, 21.6% of adults in Nebraska report no leisure-time physical activity, versus 22.5% nationally. Activity level is one of several factors a provider weighs alongside weight history and overall health.
| Measure | Nebraska | National |
|---|---|---|
| Adult obesity (2024) | 37.6% | 33.1% |
| No leisure-time physical activity (2024) | 21.6% | 22.5% |
Source: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System, 2024 release. Figures reflect self-reported height and weight. Full sources and methodology are listed at the bottom of this page.
Embed this chart on your site (free)
Copy this code. It credits Transformation Health with a link back to this page.
How Nebraska compares to other states
Nebraska ranks 7th of 51 states and DC for adult obesity. See how nearby-ranked states compare:
- Alabama obesity and GLP-1 access – 38.9% adult obesity (rank 5)
- Indiana obesity and GLP-1 access – 38.4% adult obesity (rank 6)
- Kansas obesity and GLP-1 access – 37.6% adult obesity (rank 8)
- Tennessee obesity and GLP-1 access – 37.6% adult obesity (rank 9)
Or compare every state in one table.
Does Nebraska Medicaid cover GLP-1 medications for weight loss?
Based on available information, Nebraska Medicaid generally does not cover GLP-1 medications prescribed specifically for weight loss. Coverage rules change frequently, vary by plan, and almost always require prior authorization when weight-management GLP-1s are covered at all. Confirm your current benefits directly with Nebraska Medicaid or your plan administrator before making any decisions.
Nationally, obesity-drug coverage in Medicaid remains limited: only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and several states have narrowed or ended coverage since. Coverage for type 2 diabetes is more common and is separate from weight-management coverage.
GLP-1 telehealth options in Nebraska
Many Nebraska residents look for a cash-pay telehealth route when insurance does not cover weight-management GLP-1s. Transformation Health does not currently operate in Nebraska, so it is not available here at this time. If you live in Nebraska and want to explore GLP-1 treatment, a locally licensed provider or an in-state telehealth service can discuss whether it is appropriate for you. You can still read how GLP-1 medications work for background.
Compounded semaglutide and tirzepatide in Nebraska
Transformation Health does not currently offer compounded semaglutide or compounded tirzepatide to Nebraska residents, so you cannot start a compounded GLP-1 program from this page. Compounded medications still require a prescription from a licensed provider. If you live in Nebraska, a locally licensed provider or an in-state telehealth service can discuss whether a GLP-1 medication is appropriate for you and what is available in Nebraska.
Who qualifies for GLP-1 weight management in Nebraska
You do not need a diabetes diagnosis to be considered for GLP-1 weight management. A licensed provider generally evaluates candidates with a body mass index (BMI) of 30 or higher, or 27 or higher when paired with a weight-related health condition such as high blood pressure, elevated cholesterol, or prediabetes. The provider reviews your full health history, current medications, and goals before deciding whether treatment is appropriate, so eligibility is always an individual determination rather than a guarantee.
On age, you must be at least 19 years old to be evaluated in Nebraska, which is higher than the usual 18 because 19 is the age of legal majority for independent healthcare decisions in Nebraska. The upper age limit is 76. A licensed provider makes the final eligibility decision.
A large share of people seeking GLP-1 weight management in Nebraska are women between roughly 35 and 50 who are navigating weight changes tied to perimenopause, when shifting hormones can make weight harder to manage even when nothing else has changed. If that describes you, the appetite and metabolic effects of GLP-1 medications are one option worth discussing with a provider. You can read more about whether GLP-1 medications are appropriate if you are not diabetic and how GLP-1 medications work.
What an all-inclusive GLP-1 program includes
Out-of-pocket cost is the question most people ask after they learn their plan does not cover weight-management GLP-1s. A transparent telehealth program bundles the pieces into one monthly membership so there are no surprise charges:
- Medication prepared by a US-based, state-licensed compounding pharmacy
- Evaluation and ongoing care from an independent, licensed provider
- Lab work through national labs such as Quest or Labcorp
- Weight-management coaching and check-ins
- Shipping to your door, with no hidden fees and the ability to cancel anytime
Because compounded medications are not FDA-approved and are not the same as FDA-approved generic drugs, a provider will explain what that means for you before anything is prescribed.
How to Get GLP-1 in Nebraska
Transformation Health does not currently offer its compounded GLP-1 program to Nebraska residents, so there is no online assessment to complete here. If you live in Nebraska and want to explore GLP-1 medication for weight management, the practical next step is to talk with a locally licensed provider or an in-state telehealth service about whether it is appropriate for you and what is available in Nebraska.
You can still use the Nebraska obesity and Medicaid data above, read how GLP-1 medications work, or compare other states on the GLP-1 by state page.
Data sources and methodology
- Adult obesity and physical inactivity: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System. Nebraska figures are from the 2024 data release; the national comparison is 33.1% (2024). Obesity prevalence is the percentage of adults with a body mass index of 30 or higher, based on self-reported height and weight, so figures may differ from measured surveys such as NHANES. Physical inactivity is the share of adults reporting no leisure-time physical activity (2024).
- Medicaid coverage: KFF, Medicaid Coverage of and Spending on GLP-1s, as of January 2026. State Medicaid coverage of GLP-1 medications for weight loss changes frequently and is summarized here for general information only. Always confirm current benefits and prior-authorization rules directly with Nebraska Medicaid or your plan.
- Data current as of: 2024 CDC release. Page last updated: July 1, 2026.
Important: Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. Medicaid coverage information is general, changes frequently, and should be confirmed with your state program. All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual.